UNSPSC 85532032: Supplement left lesser saphenous vein with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left lesser saphenous vein with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06US4JZ

UNSPSC 85532032 Supplement left lesser saphenous vein with synthetic substitute, percutaneous endoscopic approach is a Commodity code with a scope that does not align with recent state and local procurement activity. The code nominally describes a specific surgical vascular procedure, yet the recent opportunities posted under it span independent medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which involve vein supplementation or endoscopic surgical techniques. The mismatch suggests either systematic tagging misalignment in the posting system or that this code has been applied to healthcare administration and staffing services well outside its intended commodity scope.

The recent opportunities originate from diverse issuing bodies including city retirement offices (Phoenix), municipal health plans (Long Beach), state transportation departments (Washington), county juvenile justice systems (Harris County), county human resources and benefits operations (Collier County), and regional health systems (Santa Clara County), posted across Arizona, California, Florida, and Washington with response dates primarily in October 2026. No single jurisdiction appears more than once among the recent postings, and the activity does not support a coherent procurement category around the code's stated surgical procedure. Given the evident misalignment between the code's nominal scope and what state and local buyers are actually soliciting under it, this code shows little reliable signal for business development professionals pursuing opportunities in vascular surgery, medical devices, or related clinical services.